Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
158.77B | 159.23B | 135.01B | 124.08B | 83.42B | 98.40B | Gross Profit |
35.30B | 36.31B | 22.92B | 15.01B | -4.13B | -5.09B | EBIT |
28.62B | 29.47B | 16.49B | 9.60B | -9.53B | -10.47B | EBITDA |
34.91B | 33.23B | 23.89B | 15.17B | -3.97B | -14.49B | Net Income Common Stockholders |
30.96B | 26.25B | 19.95B | 11.19B | -8.42B | -18.78B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
71.06B | 90.14B | 55.39B | 29.46B | 25.28B | 13.51B | Total Assets |
199.21B | 209.04B | 174.79B | 124.90B | 123.72B | 111.56B | Total Debt |
11.83B | 18.24B | 13.32B | 11.94B | 15.23B | 17.59B | Net Debt |
-59.23B | -71.90B | -42.07B | -17.52B | -10.05B | 4.08B | Total Liabilities |
97.62B | 103.89B | 94.89B | 74.94B | 86.55B | 71.20B | Stockholders Equity |
101.22B | 105.14B | 79.68B | 49.96B | 37.17B | 40.36B |
Cash Flow | Free Cash Flow | ||||
0.00 | 32.42B | 25.47B | 6.92B | 13.56B | -30.56B | Operating Cash Flow |
0.00 | 37.73B | 27.41B | 9.00B | 15.10B | -26.64B | Investing Cash Flow |
0.00 | -5.26B | -1.92B | -1.26B | -715.00M | -4.07B | Financing Cash Flow |
0.00 | 2.29B | 571.00M | -3.38B | -2.50B | -124.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | €189.99B | 7.24 | 28.05% | 1.07% | 17.94% | 31.45% | |
78 Outperform | ¥9.45B | 7.84 | 2.74% | 7.08% | 165.76% | ||
74 Outperform | $251.43B | 6.47 | 24.36% | 0.82% | 4.38% | 54.63% | |
70 Neutral | ¥9.43B | 9.27 | 0.71% | -3.74% | -55.02% | ||
63 Neutral | $770.21M | 8.64 | 4.79% | 3.72% | 1.11% | -32.34% |